Eterus Capital has partnered with Dr. Martin to expand its dental clinic network
Dr. Martin Dental Clinic, a leading network of dental clinics in Slovakia, has received a significant investment from Eterus Capital and Ethernum Capital to support its expansion across the country. The group aims to become Slovakia’s largest dental care provider through a "buy-and-build" strategy, combining new clinic openings with acquisitions.
Eterus Capital is a private equity fund founded in 2008, specializing in supporting small and medium-sized enterprises with proven business models and growth potential. The fund focuses on minority investments, ensuring management control remains with the original shareholders. Over the years, Eterus Capital has provided more than US$41 million (€40 million) in funding to over 20 companies. Its portfolio includes prominent brands such as Sygic, HOPIN, eyerim, Saneca Pharmaceuticals, Groupsolver and MTBIKER.
Dr. Martin is a leading private dental care group in Slovakia, with over a decade of experience offering comprehensive services such as implantology, prosthetics and other restorative and aesthetic dental treatments. The group currently operates four modern dental clinics and a pediatric clinic under the Dr. Martinko brand, employing approximately 130 professionals.
Oaklins’ team in Slovakia advised Eterus Capital on this transaction.


Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more